HealthEquity (HQY) Q1 2027 earnings review
Spectacular Margins Mask Sluggish Core Revenue Growth
HealthEquity delivered a massive bottom-line beat, with Net Income soaring 29% and Adjusted EBITDA margins expanding 400 bps to 46%. This profitability was driven by a sheer 11% YoY reduction in service costs—a direct result of AI and cloud migration investments. However, the top-line story is less impressive. Total revenue grew a stable 7%, but the highest-margin engine, Custodial Revenue, carried the weight (+11.4%). Service and Interchange revenues are decelerating laggards. Management's confidence remains sky-high, evidenced by a massive new $1.0 billion buyback authorization, but slowing cash asset accumulation (+3% YoY) warrants monitoring.
🐂 Bull Case
Service costs dropped from $88.0M to $78.3M despite revenue growing by $24M YoY. The 'Rule of 50' flywheel is working flawlessly, driving gross margin up to 72.3%.
The company repurchased $123M in Q1 and immediately authorized a staggering $1.0B new program, establishing a massive floor for long-term EPS growth.
🐻 Bear Case
Service revenue grew a meager 2.6% YoY, acting as a severe top-line anchor despite a 38% boom in invested assets.
HSA Cash grew just 3% YoY as members aggressively shift funds into investments. This structural mix shift starves the lucrative custodial revenue engine of new capital.
⚖️ Verdict: 🟢
Bullish. The top-line deceleration in Service and Interchange revenues is a valid concern, but the structural margin improvements and aggressive $1B buyback make the bottom-line growth highly durable.
Key Themes
AI & Efficiency Drive Margin Expansion
Accelerating. Gross margin surged to 72.3% from 67.8% a year ago. The standout metric is Service Costs, which outright declined 11% YoY to $78.3M despite a growing account base. Management's prior investments in 'Agentic AI' chat, expedited claims, and 100% cloud migration are yielding profound operating leverage, successfully neutralizing the manual service and fraud expenses that plagued previous years.
Tipping Point: Investments Surpass Cash
Reversing. For the first time, HSA Investments ($19.6B, +38% YoY) have eclipsed HSA Cash ($17.5B, +3% YoY). While management celebrates the 'save, spend, invest' flywheel, this structural shift means the highest-margin custodial revenue engine is seeing slower volume inputs. Future service fee monetization from these investments must offset the lost custodial yield opportunity.
Capital Returns Go Supernova
Accelerating. HealthEquity exhausted $123M on stock repurchases in Q1 and immediately authorized a new $1.0 billion program. This is a massive escalation compared to the $300M program completed in FY26. It signals deep confidence in free cash flow durability and provides a strong tailwind for EPS growth.
Laggard Segments: Service & Interchange
Decelerating. While overall revenue grew 7%, the growth was heavily uneven. Service revenue grew a sluggish 2.6% YoY to $122.9M, significantly underperforming the company average. Interchange revenue also decelerated to 5.1% growth, down from 14% a year ago. If custodial yields normalize, these core operational revenues must accelerate to sustain the top line.
Stagnant Complementary Account Growth
Stable (but weak). Total accounts grew 4% YoY to 17.8M, but the Consumer-Directed Benefits (CDBs) segment was completely flat at 7.15M accounts (0% YoY growth). While new HSA sales ticked up to 172k (from 150k last year), the broader cross-selling engine appears stalled, likely reflecting a softer macro hiring environment.
De-Risking via Interest Rate Hedging
Stable. Custodial revenue remains the primary profit engine ($174.3M, +11.4% YoY). Management's aggressive strategy to lock in future yields using Treasury forward contracts is insulating the company from near-term rate cuts. The projected average annualized yield for FY27 is expected to remain healthy, guaranteeing near-term custodial stability.
Other KPIs
Accelerating. Operating cash flow surged to $97.5M (up 50% YoY from $64.7M). After subtracting CapEx of $16.3M ($15.9M software + $0.4M PPE), free cash flow was $81.2M. This robust cash generation easily funded the aggressive quarter of stock repurchases.
Reversing. Up 15% YoY from the 150,000 low posted in 26Q1, demonstrating some resilience in the enterprise sales pipeline despite broader macroeconomic hiring concerns.
Guidance
Stable. The midpoint of $1.415B implies 7.7% YoY growth over FY26's $1.313B, perfectly in line with the 7% growth posted in Q1. Management sees a durable, if unspectacular, top-line trajectory.
Decelerating. The midpoint implies ~11.1% YoY growth over FY26's $566M. Given that Q1 grew at 17%, this guidance suggests management is either baking in conservative expectations or preparing for tougher margin comparisons in the second half of the year.
Accelerating. The midpoint of $4.695 implies a ~17.3% YoY growth over FY26 ($4.00), largely bolstered by the aggressive reduction in share count.
Key Questions
Capital Allocation Shift
With the massive $1B repurchase authorization, how does M&A fit into your capital allocation priority? Are portfolio valuations currently too high to justify acquisitions?
Service Revenue Disconnect
Service revenue grew only 2.6% YoY despite HSA investments surging 38%. Why isn't the explosion in invested assets translating into faster service fee growth?
AI Efficiency Runway
Service costs dropped an impressive 11% YoY. Have we reached the floor for AI-driven efficiency gains, or is there still runway to compress service costs further in FY27?
ACA Retail Pipeline
How is the rollout of the ACA Bronze direct-to-consumer platform performing, and when do you expect it to become a material driver of new account growth?